Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A coming of age for immune checkpoint inhibitors in cancer.
Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-ß-driven pulmonary vascular remodeling.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A coming of age for immune checkpoint inhibitors in cancer.
A coming of age for immune checkpoint inhibitors in cancer. Immunotherapy. 2019 06; 11(8):647-650.
View in:
PubMed
subject areas
Aging
Antineoplastic Agents
Humans
Neoplasms
authors with profiles
Ryan D Nipp